Literature DB >> 17092488

Beta-adaptin: key molecule for microglial scavenger receptor function under oxidative stress.

Natalia Manzano-León1, Blanca Delgado-Coello, Margarita Guaderrama-Díaz, Jaime Mas-Oliva.   

Abstract

Scavenger receptors internalize chemically modified low density lipoprotein particles (ac-LDL) and other ligands through the process of receptor-mediated endocytosis. During this investigation using amyloid-beta as a natural ligand for the SR, we studied under a ligand-induced oxidative stress condition, changes in protein expression of several adaptor proteins important in the organization of the endocytic machinery in microglia and macrophages. Differential expression experiments of beta-adaptin, alpha-adaptin, SR-AI, and SR-BI in RAW (macrophages) and EOC (microglia) cells were performed according to dosage and exposure time to amyloid-beta. Our results show that according to dosage, amyloid-beta produces an oxidative stress state that importantly affects the availability of beta-adaptin. Under these conditions, RT-PCR assays show that beta-adaptin mRNA is normally synthesized, reason why protein translation or protein structure of beta-adaptin might be altered. These observations might have impact in the understanding of the mechanisms microglia employ to process amyloid-beta in the brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17092488     DOI: 10.1016/j.bbrc.2006.10.077

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

2.  Particulate matter promotes in vitro receptor-recognizable low-density lipoprotein oxidation and dysfunction of lipid receptors.

Authors:  Natalia Manzano-León; Jaime Mas-Oliva; Laura Sevilla-Tapia; Rocío Morales-Bárcenas; Jesús Serrano; Marie S O Neill; Claudia M García-Cuellar; Raúl Quintana; Inés Vázquez-López; Alvaro R Osornio-Vargas
Journal:  J Biochem Mol Toxicol       Date:  2013-01-07       Impact factor: 3.642

3.  Amyloidogenic properties of a D/N mutated 12 amino acid fragment of the C-terminal domain of the Cholesteryl-Ester Transfer Protein (CETP).

Authors:  Victor García-González; Jaime Mas-Oliva
Journal:  Int J Mol Sci       Date:  2011-03-21       Impact factor: 5.923

Review 4.  A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease.

Authors:  Branden Stansley; Jan Post; Kenneth Hensley
Journal:  J Neuroinflammation       Date:  2012-05-31       Impact factor: 8.322

5.  A Novel β-adaptin/c-Myc Complex Formation Modulated by Oxidative Stress in the Control of the Cell Cycle in Macrophages and its Implication in Atherogenesis.

Authors:  Victor García-González; Jaime Mas-Oliva
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

6.  Microenvironmentally controlled secondary structure motifs of apolipoprotein A-I derived peptides.

Authors:  Paola Mendoza-Espinosa; Danai Montalvan-Sorrosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2014-04-20       Impact factor: 3.396

7.  The C-terminal Domain Supports a Novel Function for CETPI as a New Plasma Lipopolysaccharide-Binding Protein.

Authors:  Victor García-González; Nadia Gutiérrez-Quintanar; Jaime Mas-Oliva
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

8.  Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions.

Authors:  Wenfei Liu; Orjona Taso; Rui Wang; Sevinc Bayram; Andrew C Graham; Pablo Garcia-Reitboeck; Anna Mallach; William D Andrews; Thomas M Piers; Juan A Botia; Jennifer M Pocock; Damian M Cummings; John Hardy; Frances A Edwards; Dervis A Salih
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.